Yu, Lei
https://orcid.org/0000-0002-7288-2458
Mayo Clinic
Beijing InnoCare Pharma Tech Co., Ltd. (China)
Citations 1
438 | ORELABRUTINIB FOR THE TREATMENT OF RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA: EFFICACY AND SAFETY RESULTS FROM A GLOBAL PHASE 1/2 STUDY
Wang, Y., D’Olimpio, James, Anz, Bertrand, Kryachok, Irina, Gallinson, David, Nogaieva, L., Morrison, David G., Chaudhry, A., Gabrail, N., Muñoz, Judith Peñafiel, Hou, J. , Amin, Bijal , Seneviratne, Lasika, Levi, I., Rekhtman, Grigoriy, Lukavetskyy, Les M., Kio, Ebenezer A., Dunder, Steven, Gardner, F., Huynh, Carissa A., Ursol, G., Popovych, Yuriy, Dreisbach, Luke, Hashmi, Mehmood, Yu, Lei , Zhao, Rui , Wang, Yucai , Flinn, Ian W. , Morrison, D., Munoz, J., Amin, B., Huynh, C., Preis, Meir , Ursol, Grygoriy, Popovych, Y., Zhao, R., Wang, M.
Hematological Oncology | June 16, 2025 | Volume: 43 | Issue: S3 | Pages: No page available
